A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:
Back to home » Top Stories » CROI 2010
17th Conference on Retroviruses and Opportunistic Infections
CROI 2010 17th Conference on Retroviruses and Opportunistic Infections
Moscone Center West
San Francisco, CA
February 16-19, 2010

HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

February 18, 2010

By David Evans

HIV infection increases the risk of developing lung cancer by about 80 percent, according to a study presented Wednesday, February 17, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. However, it is smoking among people living with HIV that poses the greatest risk of developing lung cancer.

Researchers have long known that people with HIV are more likely to get certain cancers, such as Kaposi’s sarcoma, especially when their CD4 cell counts drop. They are called AIDS-related cancers (ARC), and the rates of these opportunistic illnesses have fallen dramatically since the introduction of combination antiretroviral (ARV) therapy in the late 1990s.

Other cancers, such as lung cancer, have not traditionally been associated with HIV, but studies conducted during the past couple of years have indicated that people with HIV might be at increased risk of developing such cancers, especially as they live longer and contend with other disease risk factors.

To determine whether HIV adds to the risk of developing lung cancer, Keith Sigel, MD, MPH, from Mount Sinai School of Medicine in New York City and his colleagues examined the medical records of people receiving care through veterans administration (VA) clinics and hospitals. So that accurate rates of smoking history could be factored into the study—previous studies on lung cancer in HIV have not controlled for this aspect very well—Sigel’s team focused on veterans who had also filled out a 1999 survey on tobacco use.

In all, Sigel and his colleagues narrowed down a database of more than 100,000 veterans to 3,707 HIV-positive and 9,980 HIV-negative participants. The median follow-up was eight years. Basic characteristics between the two groups were similar. The median age of both groups was 47; many were non-white and 98 percent were male. With respect to smoking, the two groups differed somewhat. HIV-positive participants were more likely to smoke currently or to have quit smoking only recently.

There were just over 200 diagnosis of lung cancer in both groups combined during the follow-up period.

Sigel’s team found that HIV itself, after factoring out other characteristics such as smoking and age, was associated with an increased risk for developing lung cancer—an 80 percent increase in the relative risk compared with HIV-negative participants. Yet the increased risk associated solely with HIV infection was modest compared with smoking history. Current smokers and people who had quit within the past year were almost 10 times as likely to develop lung cancer as people who’d never smoked. People who’d quit more than one year earlier were just over five times as likely to develop lung cancer. People who reported smoking only occasionally were about 3.5 times more likely to develop lung cancer.

Interestingly, Hispanic participants were less likely to develop lung cancer than white or black participants, and the author commented that this has been found in several other studies.

Sigel acknowledged that they were not able to determine whether ARVs influenced the development of lung cancer. The rates of some types of cancers decrease when ARV therapy increases CD4 cells and controls viral replication.

Sigel stated that segmenting people into groups (such as non-smokers, occasional smokers, recently quit smokers and smokers who’d quit less recently) has been validated in other studies to produce a good assessment of a person’s lung cancer risk. He said, however, that determining the actual quantities of cigarettes a person has smoked recently, or ever, would have given an even more detailed picture of smoking’s influence on lung cancer risk.

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Steve, Morristown, NJ, 2010-02-24 20:51:31
Scare tactics again. Read further. YET THE INCREASED RISK ASSOCIATED SOLELY WITH HIV INFECTION WAS MODEST COMPARED WITH SMOKING HISTORY. CURRENT SMOKERS AND PEOPLE WHO HAD QUIT WITHIN THE PAST YEAR WERE ALMOST 10 TIMES AS LIKELY TO DEVELOP LUNG CANCER AS PEOPLE WHO'D NEVER SMOKED. People who’d quit more than one year earlier were just over five times as likely to develop lung cancer. PEOPLE WHO REPORTED ONLY SMOKING OCCASIONALLY WERE ABOUT 3.5 TIMES MORE LIKELY TO DEVELOP LUNG CANCER. Enough!!

comments 1 - 1 (of 1 total)    

More from CROI 2010

HIV/AIDS Complications

March 9, 2010
HIV and the Brain: Part 2
March 8, 2010
Cancer Risks and HIV
HIV and the Brain: Part 1
March 1, 2010
HIV and Bone Health
February 25, 2010
Bone Fracture Risk Higher Among People Living With HIV
Vitamin D Deficiency Common Among HIV Positive
February 24, 2010
HIV in the Brain Usually Matches Levels in the Blood
Hep C Treatment Might Also Guard Against HIV Disease Progression
February 23, 2010
Truvada and Norvir-Boosted Reyataz More Likely to Cause Bone Loss in ACTG Study
Maintaining Higher CD4s Protects Against Brain Damage
February 20, 2010
HIV and Heart Disease Risks
February 19, 2010
Increased Risk of Chronic Kidney Disease Linked to Tenofovir and Atazanavir
Non-AIDS Cancer Risk Decreases With Higher CD4 Cell Counts
Smoking Cessation Reduces Cardiovascular Disease Risk in HIV
February 18, 2010
H1N1 Meets HIV
HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

HIV Transmission and Prevention

March 8, 2010
HIV Prevention: On the Verge of Success?
HIV Treatment in Southern Africa
March 1, 2010
One in Six New HIV Cases Involves Drug-Resistant Virus
February 22, 2010
Routine HIV Testing Proving Successful in Washington, DC
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies

Starting and Switching Treatment

March 2, 2010
Normal Life Expectancy With Maintenance of CD4s Above 500
February 22, 2010
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies
February 19, 2010
No Efficacy Differences in ACTG Study Comparing Sustiva or Reyataz with either Epzicom or Truvada
February 18, 2010
Once-Daily Prezista Effective, Safer for HIV Treatment-Experienced Patients

Experimental HIV Drugs

March 9, 2010
New Treatments for HIV: Part 1
New Treatments for HIV: Part 2
February 18, 2010
New CCR5 Antagonist Shows Promise in Early Study
Vicriviroc Falls Short in Treatment-Experienced HIV Studies
February 17, 2010
Quad Pill and Boosting Drug Show Well in Studies


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.